INS (Myc-DDK-tagged)-Human insulin (INS), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Products
INS (myc-DDK-tagged) - Human insulin (INS), transcript variant 4
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
INS (Myc-DDK tagged) - Homo sapiens insulin (INS), transcript variant 3
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
INS (Myc-DDK tagged) - Homo sapiens insulin (INS), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
INS - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
INS (tGFP-tagged) - Human insulin (INS), transcript variant 4
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Transient overexpression lysate of insulin (INS)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression of INS, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
INS - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
INS - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Insulin (INS) (+Proinsulin) mouse monoclonal antibody, clone D3E7 (5B6/6), Purified
| Applications | ELISA, IHC |
| Reactivities | Bovine, Human, Mouse, Porcine, Rat |
Rabbit Polyclonal Anti-INS Antibody
| Applications | IHC |
| Reactivities | Human |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Conjugates
Clonalities
Mutants
Assay Types
QC Levels
Pathways
- Insulin signaling pathway (41)
- Maturity onset diabetes of the young (41)
- Oocyte meiosis (41)
- Progesterone-mediated oocyte maturation (41)
- Prostate cancer (41)
- Regulation of actin cytoskeleton (41)
- Regulation of autophagy (41)
- Type I diabetes mellitus (41)
- Type II diabetes mellitus (41)
- mTOR signaling pathway (41)
